Neurology Central

Study suggests adult medulloblastoma patients should receive post-surgical adjuvant chemotherapy

Researchers from Yale Cancer Center (New Haven, CT, USA) have evaluated the survival impact of adjuvant chemotherapy in adult medulloblastoma (MB) patients. Chemotherapy is routinely utilized as treatment for pediatric MB, however the effectiveness in adult patients is unclear.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.